Stock-Based Compensation (Details) (USD $)	3 Months Ended		9 Months Ended				12 Months Ended	9 Months Ended	3 Months Ended	9 Months Ended
	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013	Sep. 29, 2012	Sep. 28, 2013 Performance Shares [Member]	Sep. 28, 2013 Stock Options [Member]	Dec. 29, 2012 Stock Options [Member]	Sep. 28, 2013 Restricted Stock Units (RSUs) [Member]	Sep. 28, 2013 2007 Long-term Equity Incentive Plan [Member] Restricted Stock Units (RSUs) [Member]	Sep. 28, 2013 2007 Long-term Equity Incentive Plan [Member] Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation provision	$ 900,000	$ 1,500,000	$ 2,879,000	$ 4,445,000
Unrecognized compensation cost related to unvested share-based compensation grants	5,200,000		5,200,000
Weighted average amortization period of unvested share-based compensation grants			1 year 3 months 3 days
Narrative Disclosures [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value									300,000	1,200,000
Options, Outstanding [Roll Forward]
Options outstanding as of the year ended						2,226,000
Options granted						189,500
Options exercised						(10,000)
Options forfeited						(512,500)
Options outstanding as of the year ended						1,893,000	2,226,000
Options Outstanding, Weighted Average Exercise Price [Roll Forward]
Wt avg exercise price outstanding as of the year ended						$ 7.75
Wt avg exercise price granted						$ 2.00
Wt avg exercise price exercised						$ 2.00
Wt avg exercise price forfeited						$ 15.05
Wt avg exercise price outstanding as of the year ended						$ 5.23	$ 7.75
Wt Avg Exercise Price, Contractual Term, Intrinsic Value, Options, Additional Disclosures [Abstract]
Wt avg remain contract term outstanding as of the year ended						2 years 7 months	2 years 8 months 12 days
Intrinsic value outstanding as of the year ended						172,000	0
Intrinsic value exercised as of the year ended						0
Exercisable, options, as of the year ended						1,381,625
Exercisable, wt avg exercise price as of the year ended						$ 5.44
Exercisable, wt avg remaining contractual term as of the year ended						2 years 1 month
Exercisable, intrinsic value as of the year ended						$ 0
Weighted Average, Fair Value Assumptions [Abstract]
Weighted average fair value of option grants during the year						$ 1.01
Expected option life in years						4 years 3 months
Risk-free interest rate						0.50%
Expected volatility						65.70%
Expected dividend yield						0.00%
Nonvested, Restricted Shares and RSUs, Number of Shares [Roll Forward]
Unvested as of the year ended (shares)					0			1,074,340
Granted (shares)					730,500			549,500
Vested (shares)					0			(492,500)
Forfeited (shares)					(7,500)			(1,250)
Unvested as of the year ended (shares)					723,000			1,130,090
Nonvested, Restricted Shares and RSUs, Weighted Average Grant Date Fair Value [Roll Forward]
Unvested as of the year ended (fair value)					$ 0			$ 5.44
Granted (fair value)					$ 2.00			$ 2.00
Vested (fair value)					$ 0.00			$ 5.71
Forfeited (fair value)					$ 2.00			$ 5.62
Unvested as of the year ended (fair value)					$ 2.00			$ 3.65